Alkeon Capital Management LLC Grows Position in BWX Technologies, Inc. $BWXT

Alkeon Capital Management LLC lifted its position in BWX Technologies, Inc. (NYSE:BWXT) by 0.2% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 1,580,848 shares of the technology company’s stock after buying an additional 2,800 shares during the quarter. Alkeon Capital Management LLC’s holdings in BWX Technologies were worth $273,234,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds have also recently modified their holdings of BWXT. Aventura Private Wealth LLC purchased a new stake in shares of BWX Technologies in the fourth quarter worth about $29,000. WFA of San Diego LLC purchased a new stake in shares of BWX Technologies in the second quarter worth about $29,000. Strategic Advocates LLC purchased a new stake in shares of BWX Technologies in the third quarter worth about $32,000. Tucker Asset Management LLC purchased a new stake in shares of BWX Technologies in the fourth quarter worth about $36,000. Finally, Strategic Investment Solutions Inc. IL lifted its holdings in shares of BWX Technologies by 300.0% in the third quarter. Strategic Investment Solutions Inc. IL now owns 200 shares of the technology company’s stock worth $37,000 after buying an additional 150 shares in the last quarter. 94.39% of the stock is owned by hedge funds and other institutional investors.

BWX Technologies Stock Up 0.5%

Shares of BWX Technologies stock opened at $194.32 on Tuesday. The company has a debt-to-equity ratio of 1.58, a quick ratio of 2.33 and a current ratio of 2.40. BWX Technologies, Inc. has a 52-week low of $133.84 and a 52-week high of $241.82. The stock has a market capitalization of $17.80 billion, a price-to-earnings ratio of 51.96, a P/E/G ratio of 3.19 and a beta of 0.73. The company’s 50 day moving average price is $209.09 and its 200-day moving average price is $200.35.

BWX Technologies (NYSE:BWXT) last announced its quarterly earnings results on Monday, May 4th. The technology company reported $1.12 EPS for the quarter, topping analysts’ consensus estimates of $0.92 by $0.20. BWX Technologies had a return on equity of 31.33% and a net margin of 10.20%.The company had revenue of $860.22 million during the quarter, compared to analyst estimates of $837.47 million. During the same quarter last year, the firm posted $0.91 earnings per share. The firm’s revenue was up 26.1% on a year-over-year basis. BWX Technologies has set its FY 2026 guidance at 4.600-4.750 EPS. Equities research analysts forecast that BWX Technologies, Inc. will post 4.71 EPS for the current year.

BWX Technologies Announces Dividend

The firm also recently announced a quarterly dividend, which was paid on Friday, June 5th. Stockholders of record on Tuesday, May 19th were issued a dividend of $0.27 per share. This represents a $1.08 dividend on an annualized basis and a dividend yield of 0.6%. The ex-dividend date was Tuesday, May 19th. BWX Technologies’s payout ratio is 28.88%.

Analyst Upgrades and Downgrades

BWXT has been the topic of a number of recent analyst reports. TD Cowen initiated coverage on shares of BWX Technologies in a research note on Thursday, March 12th. They issued a “buy” rating and a $230.00 target price on the stock. Truist Financial raised their target price on shares of BWX Technologies from $205.00 to $212.00 and gave the company a “hold” rating in a research note on Monday, May 11th. BTIG Research raised their target price on shares of BWX Technologies from $225.00 to $235.00 and gave the company a “buy” rating in a research note on Thursday, February 26th. Zacks Research cut shares of BWX Technologies from a “strong-buy” rating to a “hold” rating in a research report on Monday, May 11th. Finally, Wells Fargo & Company started coverage on shares of BWX Technologies in a research report on Wednesday, April 1st. They set an “underweight” rating and a $200.00 price target on the stock. Two research analysts have rated the stock with a Strong Buy rating, eight have given a Buy rating, four have assigned a Hold rating and one has given a Sell rating to the company. According to MarketBeat, the stock has an average rating of “Moderate Buy” and a consensus price target of $228.00.

Insiders Place Their Bets

In other news, CEO Rex D. Geveden sold 10,000 shares of BWX Technologies stock in a transaction dated Tuesday, May 12th. The stock was sold at an average price of $204.81, for a total value of $2,048,100.00. Following the completion of the transaction, the chief executive officer owned 202,491 shares of the company’s stock, valued at $41,472,181.71. The trade was a 4.71% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CFO Michael Thomas Fitzgerald sold 2,417 shares of BWX Technologies stock in a transaction dated Monday, May 11th. The stock was sold at an average price of $209.25, for a total value of $505,757.25. Following the completion of the transaction, the chief financial officer directly owned 6,884 shares of the company’s stock, valued at approximately $1,440,477. This represents a 25.99% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Insiders own 0.60% of the company’s stock.

About BWX Technologies

BWX Technologies, Inc (NYSE: BWXT) is a specialized supplier of nuclear components and services, primarily serving the U.S. government and commercial markets. The company’s core expertise lies in the design, fabrication and servicing of nuclear propulsion systems for the U.S. Navy, where it supports the maintenance and overhaul of naval nuclear reactors. In addition to defense applications, BWXT develops small modular reactors (SMRs), nuclear fuel and related technologies for non‐defense power generation, offering scalable solutions to meet evolving energy and industrial demands.

Beyond propulsion and power systems, BWXT is a leading producer of medical radioisotopes used in diagnostic imaging and cancer treatment.